Capricor Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
CAPR chart
What traders are saying about $CAPR
Latest postsCapricor Therapeutics, Inc. news
- Kaos Capital demands Capricor board reset amid soaring costs
scanx.trade ·
- Discipline and Rules-Based Execution in CAPR Response
Stock Traders Daily ·
- Weekly Recap: Nov 22 FDA decision with HOPE‑3 data and 11% share drop
TradingView ·
- Capricor Therapeutics, Inc. Estimates – NASDAQ:CAPR
TradingView ·
- Capricor Therapeutics (CAPR) Institutional Ownership 2026
MarketBeat ·
- CAPR Stock on Track For Worst Month Since July AdCom Vote On Deramiocel As November FDA Decision Nears
stocktwits.com ·
- CAPR Stock Rises Nearly 5% As Capricor Presents Heart Data For Deramiocel Ahead Of November FDA Decision
stocktwits.com ·
- Capricor Highlights Two-Year Deramiocel Data as FDA Decision Nears
marketbeat.com ·
- Capricor’s DMD Therapy Shows 76% Slower Upper-Limb Decline — This Analyst Expects A Complete Response Letter In November
stocktwits.com ·
- Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress
Yahoo Finance ·
- CAPR Stock Clocks Best Day In Over A Month As 24-Month Duchenne Data Airs At Medical Conference In Japan
stocktwits.com ·
- Why Did CAPR Stock Jump 20% After-Hours Today?
stocktwits.com ·
Capricor Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $22.3M | $25.2M | $2.6M |
| Net income | -$105.0M | -$40.5M | -$22.3M | -$29.0M |
| Diluted EPS | $-2.26 | $-1.15 | $-0.83 | $-1.18 |
| Total assets (year end) | $355.9M | $170.5M | $58.7M | $50.1M |
| Cash and equivalents (year end) | $287.8M | $11.3M | $14.7M | $9.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Capricor Therapeutics, Inc.
- Ticker
- CAPR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1133869
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
Frequently asked questions
What exchange is Capricor Therapeutics, Inc. listed on?
Capricor Therapeutics, Inc. trades on the Nasdaq under the ticker symbol CAPR.
What industry is Capricor Therapeutics, Inc. in?
Capricor Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Capricor Therapeutics, Inc. headquartered?
Capricor Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Capricor Therapeutics, Inc.'s fiscal year end?
Capricor Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Capricor Therapeutics, Inc. report?
Capricor Therapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.